Literature DB >> 27217099

The scaffold protein calcium/calmodulin-dependent serine protein kinase controls ATP release in sensory ganglia upon P2X3 receptor activation and is part of an ATP keeper complex.

Tanja Bele1, Elsa Fabbretti1.   

Abstract

P2X3 receptors, gated by extracellular ATP, are expressed by sensory neurons and are involved in peripheral nociception and pain sensitization. The ability of P2X3 receptors to transduce extracellular stimuli into neuronal signals critically depends on the dynamic molecular partnership with the calcium/calmodulin-dependent serine protein kinase (CASK). The present work used trigeminal sensory neurons to study the impact that activation of P2X3 receptors (evoked by the agonist α,β-meATP) has on the release of endogenous ATP and how CASK modulates this phenomenon. P2X3 receptor function was followed by ATP efflux via Pannexin1 (Panx1) hemichannels, a mechanism that was blocked by the P2X3 receptor antagonist A-317491, and by P2X3 silencing. ATP efflux was enhanced by nerve growth factor, a treatment known to potentiate P2X3 receptor function. Basal ATP efflux was not controlled by CASK, and carbenoxolone or Pannexin silencing reduced ATP release upon P2X3 receptor function. CASK-controlled ATP efflux followed P2X3 receptor activity, but not depolarization-evoked ATP release. Molecular biology experiments showed that CASK was essential for the transactivation of Panx1 upon P2X3 receptor activation. These data suggest that P2X3 receptor function controls a new type of feed-forward purinergic signaling on surrounding cells, with consequences at peripheral and spinal cord level. Thus, P2X3 receptor-mediated ATP efflux may be considered for the future development of pharmacological strategies aimed at containing neuronal sensitization. P2X3 receptors are involved in sensory transduction and associate to CASK. We have studied in primary sensory neurons the molecular mechanisms downstream P2X3 receptor activation, namely ATP release and partnership with CASK or Panx1. Our data suggest that CASK and P2X3 receptors are part of an ATP keeper complex, with important feed-forward consequences at peripheral and central level.
© 2016 International Society for Neurochemistry.

Entities:  

Keywords:  DRG; hemichannels; pain; purinergic signaling; sensory neurons

Mesh:

Substances:

Year:  2016        PMID: 27217099     DOI: 10.1111/jnc.13680

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  Time-of-Day Dependent Neuronal Injury After Ischemic Stroke: Implication of Circadian Clock Transcriptional Factor Bmal1 and Survival Kinase AKT.

Authors:  Mustafa Caglar Beker; Berrak Caglayan; Esra Yalcin; Ahmet Burak Caglayan; Seyma Turkseven; Busra Gurel; Taha Kelestemur; Elif Sertel; Zafer Sahin; Selim Kutlu; Ulkan Kilic; Ahmet Tarik Baykal; Ertugrul Kilic
Journal:  Mol Neurobiol       Date:  2017-04-18       Impact factor: 5.590

2.  In situ imaging reveals properties of purinergic signalling in trigeminal sensory ganglia in vitro.

Authors:  Arletta Nowodworska; Arn M J M van den Maagdenberg; Andrea Nistri; Elsa Fabbretti
Journal:  Purinergic Signal       Date:  2017-08-18       Impact factor: 3.765

Review 3.  P2X receptor channels in chronic pain pathways.

Authors:  Louis-Philippe Bernier; Ariel R Ase; Philippe Séguéla
Journal:  Br J Pharmacol       Date:  2017-08-17       Impact factor: 8.739

4.  Glial pannexin1 contributes to tactile hypersensitivity in a mouse model of orofacial pain.

Authors:  Regina Hanstein; Menachem Hanani; Eliana Scemes; David C Spray
Journal:  Sci Rep       Date:  2016-12-02       Impact factor: 4.379

Review 5.  Connexin43 Hemichannels in Satellite Glial Cells, Can They Influence Sensory Neuron Activity?

Authors:  Mauricio A Retamal; Manuel A Riquelme; Jimmy Stehberg; Julio Alcayaga
Journal:  Front Mol Neurosci       Date:  2017-11-16       Impact factor: 5.639

Review 6.  Purinergic Signaling in Endometriosis-Associated Pain.

Authors:  Carla Trapero; Mireia Martín-Satué
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.